BOGLE INVESTMENT MANAGEMENT L P /DE/ - ANTHERA PHARMACEUTICALS INC ownership

ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 43 filers reported holding ANTHERA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.38 and the average weighting 0.2%.

Quarter-by-quarter ownership
BOGLE INVESTMENT MANAGEMENT L P /DE/ ownership history of ANTHERA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2015$505,000
-88.1%
108,963
-84.3%
0.04%
-88.0%
Q3 2015$4,228,000
-47.3%
694,382
-25.4%
0.30%
-49.8%
Q2 2015$8,027,000
+152.1%
931,257
+30.7%
0.60%
+173.1%
Q1 2015$3,184,000712,5110.22%
Other shareholders
ANTHERA PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,431,196$2,748,0001.18%
Abingworth LLP 437,994$832,0000.50%
Broadfin Capital, LLC 1,301,622$2,499,0000.26%
Rhenman & Partners Asset Management AB 400,000$768,0000.22%
BVF INC/IL 559,624$1,074,0000.22%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,691,857$3,248,0000.12%
Perceptive Advisors 478,456$919,0000.10%
Gruss Capital Management LP 1,720,000$3,302,0000.08%
SECTORAL ASSET MANAGEMENT INC 247,961$476,0000.02%
Spark Investment Management LLC 36,400$69,0000.01%
View complete list of ANTHERA PHARMACEUTICALS INC shareholders